Product Information
FENOFIBRATE 160 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1129 per EA under NDC 00904753904. Its NADAC has been published 44 times since Oct 22, 2025.
FDA first approved this application on Jun 12, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
160 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904753904
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA213864FDA Approved
6/12/2020
TE Code
AB
On Market Since
5/22/2025
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 160 MG TABLET has been published 44 times since Oct 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1129 per EA |
|---|---|
| All-time high | $0.1259 (May 13, 2026) |
| All-time low | $0.0892 (Dec 17, 2025) |
| 52-week high | $0.1259 |
| 52-week low | $0.0892 |
| Median price | $0.1119 |
| Average price | $0.1084 |
| Largest weekly change | +12.5% (Mar 18, 2026) |
| Weeks tracked | 44 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 160 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 160 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1129 per EA (NDC 00904753904), effective Aug 19, 2026.
How has the price of FENOFIBRATE 160 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 160 MG TABLET has held within roughly two percent of its current level. It has been tracked across 44 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 160 MG TABLET?
Since Oct 22, 2025, the NADAC for FENOFIBRATE 160 MG TABLET has ranged from a low of $0.0892 (Dec 17, 2025) to a high of $0.1259 (May 13, 2026), with a median of $0.1119 per EA.
Are there cheaper alternatives to FENOFIBRATE 160 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENOFIBRATE 160 MG TABLET, is $0.1048 per EA — about 7% below FENOFIBRATE 160 MG TABLET.
Who manufactures FENOFIBRATE 160 MG TABLET?
FENOFIBRATE 160 MG TABLET (NDC 00904753904) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.